NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,891 | -77.1% | 11,125 | -57.5% | 0.00% | – |
| Q2 2023 | $12,635 | -29.5% | 26,150 | -3.9% | 0.00% | – |
| Q1 2023 | $17,933 | -40.2% | 27,225 | 0.0% | 0.00% | – |
| Q4 2022 | $30,000 | +100.0% | 27,225 | +32.4% | 0.00% | – |
| Q3 2022 | $15,000 | +36.4% | 20,555 | +12.3% | 0.00% | – |
| Q2 2022 | $11,000 | -50.0% | 18,305 | +99.4% | 0.00% | – |
| Q1 2022 | $22,000 | -89.7% | 9,180 | -79.5% | 0.00% | – |
| Q4 2021 | $214,000 | -46.2% | 44,840 | +4.6% | 0.00% | -100.0% |
| Q3 2021 | $398,000 | +947.4% | 42,885 | +1197.6% | 0.00% | – |
| Q2 2021 | $38,000 | – | 3,305 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 699,731 | $338,320 | 0.28% |
| CVI Holdings, LLC | 483,569 | $233,806 | 0.25% |
| ARMISTICE CAPITAL, LLC | 5,636,000 | $2,725,006 | 0.04% |
| Texas Capital Bank Wealth Management Services Inc | 63,290 | $30,601 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 160,700 | $77,698 | 0.00% |
| HBK Sorce Advisory LLC | 29,230 | $14,133 | 0.00% |
| United Asset Strategies, Inc. | 18,300 | $8,848 | 0.00% |
| JANE STREET GROUP, LLC | 15,052 | $7,278 | 0.00% |
| UBS Group AG | 2,758 | $1,332 | 0.00% |
| NewEdge Advisors, LLC | 2,125 | $1,028 | 0.00% |